Description
PrymaLab · Research Use Only
Semaglutide 5mg
The fill that matches how this compound is usually used
Most laboratories buying semaglutide 5mg are not studying semaglutide. They are studying something else and need a benchmark to run it against, and a benchmark arm consumes less material than the arm it exists to measure.
Specification Table
| Property | Value |
|---|---|
| Compound | Semaglutide |
| CAS number | 910463-68-2 |
| Molecular formula | C187H291N45O59 |
| Molecular weight | Approximately 4113 |
| Declared content | 5 milligrams |
| Approximate molar content | Around 1.2 micromoles |
| Position in the range | Smallest of five fills in this catalogue |
| Compound differences between fills | None |
| Typical role in published work | Active comparator rather than test article |
| Consequence of that role | Comparator arms are shorter and use less material |
| Acylation | A C18 diacid at lysine 26, which affects handling and net content |
| Non-natural residue | Aminoisobutyric acid at position 8. Covered on the 10mg page |
| Vial mass versus peptide mass | Not equal. Net peptide content resolves it |
| Chemistry | Covered on the 10mg page. It does not change with fill size |
| Storage | Sealed at minus 20°C. Do not freeze solution and do not agitate |
Who Buys a Semaglutide 5mg Vial?
Mostly people running an experiment about a different compound. A semaglutide 5mg vial is a benchmark purchase.
The 10mg page in this catalogue makes the point that semaglutide occupies an unusual position in the incretin literature, appearing far more often as the active comparator than as the subject.
That position has a direct consequence for fill size and nobody writes about it.
A comparator arm is typically one concentration, or a short series around one concentration, run alongside a test compound that gets the full range.
It consumes a fraction of what the test arm consumes.
So the study that needs 50 milligrams of its test compound frequently needs 5 of its comparator, and buying matched quantities of both is a waste of the second one.
There is a second reason the small fill suits this role. A comparator arm should ideally come from one lot for the same reasons any arm should, and a small fill covering a short arm achieves that without leaving material to degrade.
What Should Not Be Done With Two Fills?
Split one arm across a semaglutide 5mg vial and a larger one.
This is the specific failure the fill-size question produces, and it looks harmless, which is why it keeps happening.
A comparator arm run half on a 5 milligram vial and half on a 10 milligram vial has two lots inside one arm, which means any variance within that arm has an extra source that the test arm does not have.
The comparison between arms then carries a difference in materials handling that has nothing to do with the compounds.
It is a small effect and it is asymmetric, which is the property that makes it worth avoiding rather than absorbing.
The rule I would apply is that one arm gets one lot, and if that means buying a larger fill than the arm needs and discarding the remainder, buy the larger fill.
Discarding peptide feels wasteful and it is cheaper than an uninterpretable result.
What Concentration Does 5 Milligrams Give?
At 4113 daltons, a semaglutide 5mg fill comes out at about 1.2 micromoles of peptide.
Into 1 millilitre that is roughly 1.2 millimolar, and into 5 millilitres roughly 240 micromolar.
Published cell work with this class sits well below that, so the fill supports a large number of assay volumes.
The constraint again is the solution clock rather than the quantity. An acylated peptide has a limited useful life once dissolved and freezing it is not a solution.
For a comparator arm that is usually fine, because the arm is short by construction.
It stops being fine when a study runs in phases over months and the comparator arm is repeated in each phase, which is a common design and a bad fit for one reconstitution.
In that case the honest options are a fresh vial per phase, accepting the lot change and recording it, or reconstituting in portions from a larger fill.
What Should the Certificate Show?
Net peptide content with the determination named, which sets the concentration.
The full sequence, with the aminoisobutyric acid at position 8 and the acylation site at lysine 26 both stated.
Observed mass by spectrometry, since the non-natural residue is not detected by a default amino acid analysis panel and mass is therefore the primary identity method.
Purity by chromatography, with the gradient and column both named on the document.
Aggregate content by size exclusion chromatography.
Salt form.
Lot number and manufacturing date.
The mass spectrometry line does more work on this molecule than on most. A synthesis substituting alanine for the non-natural residue at position 8 gives a compound fourteen daltons lighter with a far shorter functional life, and amino acid analysis will not catch it.
What Makes a Comparator Arm Usable?
Four things, and where the semaglutide 5mg material came from is the one that gets least attention.
The comparator has to be the right compound. That sounds obvious and it is where approved-formulation confusion enters. Research-grade semaglutide is not the approved product, and a comparison against published clinical figures is a comparison against a different article.
It has to be at a concentration that means something, which usually means one drawn from published work rather than chosen for convenience.
It has to be handled identically to the test arm, including the same diluent, the same consumables and the same time in solution. A comparator prepared more carefully than the test compound is not a fair benchmark.
And it has to come from one lot, for the reason the section above sets out.
That last requirement is the one a fill-size decision determines, which is why a page about a 5 milligram vial ends up being about study design.
None of this is difficult. It is a set of decisions that get made by default when nobody makes them deliberately, and the default is usually wrong in the same direction: the test compound gets the attention and the comparator gets whatever is convenient.
How Does This Compare With the Larger Fills?
The catalogue lists five sizes and the compound in a semaglutide 5mg vial is identical to the compound in all of them.
What differs is the same thing that differs across every fill range: how much of a study one vial covers and how many lots a dataset ends up spanning.
The specific consideration here is that a comparator arm is short, so the larger fills are usually the wrong purchase for the role this compound normally plays.
A 30 milligram vial bought to supply a comparator arm will be mostly unused at the end of the study, and mostly unusable by then as well, because the solution clock does not pause between phases.
Where the larger fills make sense is a study in which semaglutide is the test article rather than the benchmark, which does happen and is the minority case.
Reading the catalogue with that in mind, the 5 milligram vial is the default and the larger ones are the exception, which is the reverse of how the range is usually presented.
Why Is Handling Symmetry the Hard Part?
Because it is invisible and it always breaks in the same direction.
A test compound gets prepared carefully. The comparator gets prepared to whatever standard is convenient that morning.
Same diluent, in principle. The same consumables, in principle, and the same tips. Same time between reconstitution and use, in principle.
In practice the test arm gets fresh stock and the comparator gets whatever was in the fridge.
That asymmetry does not cancel out. It systematically favours the test compound, which is the arm somebody wants to look good, and nobody has to intend anything for it to happen.
Prepare both arms in the same session from the same diluent lot, and record that you did.
I would want that line in a methods section before believing a head-to-head comparison, and I almost never see it.
How Should the Vial Be Handled?
Handle a semaglutide 5mg vial as an acylated peptide, which the 10mg page sets out in full.
Sealed lyophilised material holds at minus 20 degrees Celsius, dark and dry.
Let the vial reach ambient temperature before opening it, since a 5 milligram cake is small.
Add diluent down the wall and leave the cake to dissolve on its own.
No vortexing. A surface active molecule driven to an air-liquid interface associates there and does not reliably come back.
Reconstituted solution stays refrigerated and does not go into a freezer.
Rinse the vial with a second small volume. On a small fill the residue on the glass is a larger share of the total.
Aliquot on first reconstitution and use low-binding consumables at every dilution step.
Record lot, net peptide content, diluent volume, the reconstitution date and which arm of the study the vial served.
The last field is the one specific to this compound. On an article usually bought as a comparator, knowing which arm a vial supplied is what stops one lot quietly spanning two arms.
A closing note on the asymmetry problem. Nothing above requires extra equipment or extra time. It requires deciding that the comparator arm deserves the same care as the test arm, and then writing down that you gave it.
That decision is free and it is the one most likely to be skipped on a Friday afternoon.
A comparator arm worth running is worth running under the same conditions as the thing it measures against. Otherwise the number it produces is a benchmark for a different experiment, and the comparison it supports is weaker than it looks on the page.
Published Literature
Selected references on the design of the molecule, on the published comparative work and on peptide storage generally. The 10mg page carries the same list, since the compound is the same.
- Lau J, Bloch P, Schaffer L, Pettersson I, Spetzler J, Kofoed J, et al. Journal of Medicinal Chemistry. 2015;58(18):7370-7380. DOI: 10.1021/acs.jmedchem.5b00726
- Frias JP, Davies MJ, Rosenstock J, Perez Manghi FC, Fernandez Lando L, Bergman BK, et al. New England Journal of Medicine. 2021;385(6):503-515. DOI: 10.1056/NEJMoa2107519
- Willard FS, Douros JD, Gabe MB, Showalter AD, Wainscott DB, Suter TM, et al. JCI Insight. 2020;5(17):e140532. DOI: 10.1172/jci.insight.140532
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Pharmaceutical Research. 2010;27(4):544-575. DOI: 10.1007/s11095-009-0045-6
Frequently Asked Questions
Who typically buys this fill?
Laboratories studying a different compound. Semaglutide appears in the incretin literature far more often as the active comparator than as the subject.
Why does that suit a small fill?
A comparator arm is usually one concentration or a short series around one, run alongside a test compound that gets the full range. It consumes a fraction of what the test arm does.
Is there a second reason?
Yes. A short arm covered by a small fill comes from one lot without leaving material to degrade, which is what any arm should have.
What should not be done with two fill sizes?
Split one arm across a semaglutide 5mg vial and a larger one. That puts two lots inside one arm, so its variance has a source the test arm does not have, and the between-arm comparison carries a materials difference.
Is that a large effect?
No, it is small. It is also asymmetric, which is why it should be avoided rather than absorbed into the noise.
What is the rule then?
One arm, one lot. If that means buying more than the arm needs and discarding the remainder, buy it. Discarding peptide is cheaper than an uninterpretable result.
How much is 5 milligrams in molar terms?
About 1.2 micromoles, at 4113 daltons. Into 1 millilitre that is roughly 1.2 millimolar.
Is the quantity the constraint?
No, the solution clock is. An acylated peptide has a limited useful life once dissolved, and freezing it concentrates the peptide differentially rather than preserving it.
What about a study running in phases?
A comparator arm repeated across phases is a bad fit for one reconstitution. Either a fresh vial per phase with the lot change recorded, or reconstitution in portions from a larger fill.
Why does mass spectrometry matter so much here?
Because the non-natural residue at position 8 is missing from default panels. A synthesis substituting alanine there gives a molecule fourteen daltons lighter with a far shorter functional life.
Should the vial be rinsed?
Yes. On a small fill the residue left on the glass is a larger share of the total, and a second small volume of diluent recovers a useful fraction.
What extra field belongs in the record?
Which arm of the study the vial served. On an article usually bought as a comparator, that is what stops one lot quietly spanning two arms.
Compliance Statement
Semaglutide is sold exclusively for laboratory research use. It is not a drug, food, or cosmetic product, and it is not a dietary product of any kind. It is not approved by the FDA or any comparable authority for human or veterinary use, vial mass includes counterion and residual water and is not equivalent to peptide mass, its published clinical record was generated with approved formulations that are not the article supplied here and a substantial part of it comes from comparator arms in trials designed to characterise other compounds, the non-natural residue at position eight is not detected by default amino acid analysis panels so identity rests on mass rather than composition, and no compound in this range is offered for any human or veterinary purpose. This product is not intended to diagnose, treat, cure, or prevent any disease. It must not be given to humans or animals. Purchase is restricted to qualified researchers and institutions operating within applicable laws. All handling is the responsibility of the purchasing laboratory.
Other formats of Semaglutide
Semaglutide is also stocked as Semaglutide 10mg, Semaglutide 15mg, Semaglutide 20mg, Semaglutide 30mg, cagrilintide 2.5mg + semaglutide 2.5mg, Cagrilintide 5mg + Semaglutide 5mg, Cagrilintide 20mg preloaded 3ml pen and Cagrilintide 5mg. Each listing states its own quantity and concentration, and the pen and vial comparison explains what changes between formats.
18 reviews for Semaglutide 5mg